Skip to content

Neuropack X1 DC-230BARecalls & reported problems

Nihon Kohden Corporation · Main unit for MEB-2300A · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04931921102169), received between Sep 14, 2019 and Sep 14, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Energy Output Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Energy Output Problem1
  • Intermittent Energy Output1
  • Unintended Electrical Shock1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 14, 2019Energy Output Problem; Unintended Electrical Shock; Intermittent Energy Output; Energy Output Problem; Unintended Electrical Shock; Intermittent Energy Output

    THE DOCTOR REPORTED THAT THE STIMULATOR FOR THE MEB ELECTROMYOGRAPH WAS INTERMITTENTLY DISCHARGING HIGH VOLTAGE TO THE PATIENT AND WAS RECEIVING A MESSAGE TO RESET IT EACH TIME. NO PATIENT HARM WASREPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions; No Consequences Or Impact To Patient

    MAUDE report 9057736 ↗

Other STIMULATOR, ELECTRICAL, EVOKED RESPONSE devices

All STIMULATOR, ELECTRICAL, EVOKED RESPONSE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page